Quest Diagnostics and PathAI Usher New Era in AI Pathology

In a significant move in the realm of AI pathology innovation, Quest Diagnostics, a leading provider of diagnostic information services, has announced a collaboration with PathAI, a renowned entity in AI-powered pathology technology. The association is expected to fast-track the integration of digital and AI pathology, fostering enhanced efficiency in diagnosing diseases like cancer.

Quest Diagnostics Acquires PathAI Diagnostic Assets

As per the definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the division of PathAI that provides anatomic and digital pathology laboratory services. The advanced digitized laboratory of PathAI Diagnostics in Memphis, Tennessee, will transition into Quest’s AI and digital R&D facility. Furthermore, under separate agreements, Quest will secure a license for PathAI’s AISightâ„¢, a digital pathology image management system.

Significance of AI and Digital Pathology in Cancer Diagnosis

With AI and digital technologies on its site, Quest aims to significantly improve cancer care. AI pathology innovation plays a crucial role in enhancing the speed and quality of diagnosing cancer and other diseases. With PathAI’s industry-leading expertise, Quest plans to offer high-quality, efficient, and accessible innovations. In addition, the adoption of these technologies will be a major turning point for digital pathology in the U.S.

Expanding the Reach of Diagnostic Services with AI

Digital pathology allows for the creation of digital images of glass slides, facilitating electronic sharing and faster reporting of results. It also extends access to expert consultations to remote areas and addresses the challenge of workforce shortage. Quest’s strategic collaboration with PathAI will enable it to offer flexible digital slide preparation and diagnostic services, both domestically and through its Global Diagnostic Network, overseas.

To conclude, the partnership between Quest Diagnostics and PathAI marks a significant milestone in AI pathology innovation. This strategic alliance has the potential to boost the adoption of digital and AI pathology, improving diagnostic efficiency and quality, particularly in cancer care.

Don’t miss our latest Startup News: Harmonic’s Beacon ISM: A Robust Leap in Broadband Speeds

Photo of Alex


Alex is a seasoned editor and writer with a deep passion for technology and startups. With a background in journalism, content creation, and business development, Alex brings a wealth of experience and a unique perspective to the ever-changing world of innovation. As the lead editor at Startup World, Alex is committed to discovering the hidden gems in the startup ecosystem and sharing these exciting stories with a growing community of enthusiasts, entrepreneurs, and investors. Always eager to learn and stay updated on the latest trends, Alex frequently attends industry events and engages with thought leaders to ensure Startup World remains at the forefront of startup news and insights. Alex's dedication and expertise help create an engaging platform that fosters knowledge-sharing, inspiration, and collaboration among tech-savvy readers worldwide.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button